Electroceuticals Market / Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User & Region - Global Forecasts to 2026
Updated on : May 04, 2023
The global electroceuticals market in terms of revenue was estimated to be worth $16.8 billion in 2021 and is poised to reach $21.5 billion by 2026, growing at a CAGR of 5.0% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is driven by the rising government support and funding for neurological disorders, the rising geriatric population and subsequent growth in the prevalence of neurological and cardiovascular disorders, and the increasing investments and funding for research on CRM devices.
To know about the assumptions considered for the study, Request for Free Sample Report
Electroceuticals Market Dynamics
Driver: Rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders
The geriatric population is at a higher risk of developing neurologic or cardiovascular disorders. Their higher susceptibility to such disorders makes geriatrics a key segment of the overall patient pool. As a result, the growth of this population segment will ensure a continued and intensified demand for electroceutical devices such as cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators for the treatment of cardiovascular disorders and neurological disorders.
Opportunity: Emerging markets
Emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries such as Israel, Saudi Arabia, and UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the electroceuticals/bioelectric medicine market to focus on emerging countries.
Restraint: High cost of electroceutical devices
The high cost of electroceutical devices such as cochlear implants and neurostimulators is a major factor restraining market growth, particularly in price-sensitive regions such as the Asia Pacific, Latin America, and Africa. Healthcare providers, especially in developing countries such as Brazil and Mexico, have low financial resources to invest in sophisticated technologies. Moreover, the staff must be extensively trained for the efficient handling and maintenance of electroceutical devices. In line with this, extensive R&D activities are required to develop technologically advanced electroceutical devices such as cochlear implants. This results in a significant increase in the cost of manufacturing. Consequently, high-capital investments are required to carry out such activities, which only the established or major players in the market can afford. Furthermore, the top players in this market are large and well-established and enjoy a high degree of brand loyalty. Therefore, new entrants must compete with existing players and set themselves apart by developing innovative product offerings.
Challenge: The dearth of trained professionals
The placement of electroceutical devices such as neurostimulators in the desired body part requires the guidance of neurosurgeons who specialize in neural implant procedures and have a functional neurosurgery fellowship. Currently, there is a large gap between the demand and supply of neurologists worldwide. This shortage will be a concern given the projected increase in healthcare demand due to factors such as the growing patient pool and rising disease prevalence. One of the greatest limitations is the inability to produce enough trained neurosurgeons in the required amount of time. The shortage of skilled staff or neuro-physicians and neurosurgeons in major regions across the globe is expected to negatively impact the number of neurosurgery procedures carried out per year and thereby the market demand for electroceutical devices such as neurostimulators.
Cardiac pacemakers and implantable cardioverter defibrillators accounted for the largest share of the electroceuticals market, by product.
The market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators & gastric electrical stimulators, and other electrical stimulators based on product. The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the gobal market, mainly due to the increasing incidence of arrhythmias, rising prevalence of CVD, and rising technological advancements.
The implantable electroceutical devices segment accounted for the largest share of the electroceuticals market, by type.
The market is segmented into implantable electroceutical devices and noninvasive electroceutical devices based on type. The implantable electroceutical devices segment accounted for the largest share. Factors such as the rising incidence of neurological & cardiovascular disorders and an increase in the number of product approvals are driving the growth of this segment.
The hospitals, clinics, and ASCs segment accounted for the largest share in the electroceuticals market, by end user.
The market has been segmented into hospitals, clinics, and ambulatory surgical centers (ASCs); and other end users based on end user. The hospitals, clinics, and ASCs segment accounted for the largest share of the global market. The increasing adoption of electroceutical devices to serve a large patient pool is driving the growth of this segment.
North America is the largest region for electroceuticals market
The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global market. The North American market's growth can be attributed to the highly developed healthcare system in the US and Canada, increasing healthcare spending, and the increasing prevalence of cardiovascular & neurological disorders.
To know about the assumptions considered for the study, download the pdf brochure
The major players in the electroceuticals market are Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia), Axonics Modulation Technologies, Inc. (US), Neuronetics, Inc. (US), Second Sight Medical Products, Inc. (US), NeuroPace, Inc. (US), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), BIOTRONIK (Germany), Medico S.p.A. (Italy), Nurotron Biotechnology Co. Ltd. (US), MED-EL (Austria), among others.
Electroceuticals Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$16.8 billion |
|
Projected Revenue by 2026 |
$21.5 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 5.0% |
|
Market Driver |
Rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders |
|
Market Opportunity |
Emerging markets |
This report categorizes the electroceuticals market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Cardiac Pacemakers & Implantable Cardioverter Defibrillators
-
Spinal Cord Stimulators
- Chronic Pain
- Failed Back Surgery Syndrome
- Cerebral Ischemia
- Cochlear Implants
-
Deep Brain Stimulators
- Parkinson’s Disease
- Tremors
- Depression
- Other DBS Applications
-
Sacral Nerve Stimulators & Gastric Electrical Stimulators
- Urinary Incontinence
- Fecal Incontinence
- Gastroparesis
-
Transcutaneous Electrical Nerve Stimulators
- Treatment-resistant Depression
- Other TENS Applications
-
Vagus Nerve Stimulators
- Epilepsy
- Other VNS Applications
- Other Electrical Stimulators
By Type
- Implantable Electroceutical Devices
- Noninvasive Electroceutical Devices
By End User
- Hospitals, Clinics, and ASCs
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- Rest of Europe
-
Asia Pacific
- China
- Japan
- Rest of Asia Pacific
-
Latin America
- Middle East & Africa
Recent Developments
- In March 2021, Medtronic plc (Ireland) received US FDA approval for its Intellis Platform with Differential Target Multiplexed (DTM) programming to treat chronic intractable back and leg pain.
- In January 2021, Boston Scientific Corporation (US) received US FDA approval for its Vercise Genus Deep Brain Stimulation System.
- In January 2020, Medtronic plc (Ireland) acquired Stimgenics, LLC (US), a pioneer of DTM, a novel spinal cord stimulation therapy.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the electroceuticals market?
The electroceuticals market boasts a total revenue value of $21.5 billion by 2026.
What is the estimated growth rate (CAGR) of the electroceuticals market?
The global electroceuticals market has an estimated compound annual growth rate (CAGR) of 5.0% and a revenue size in the region of $16.8 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 35)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 40)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Segmental revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION APPROACH
2.3.1.3 CAGR projections
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 7 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.8.1 RISKS ASSESSMENT
2.9 COVID-19 HEALTH ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
3 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 11 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 12 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 ELECTROCEUTICALS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 ELECTROCEUTICALS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 ELECTROCEUTICALS MARKET OVERVIEW
FIGURE 15 RISING PREVALENCE OF CARDIOVASCULAR & NEUROLOGICAL DISORDERS TO DRIVE THE MARKET GROWTH
4.2 GLOBAL MARKET SHARE, BY PRODUCT, 2021 VS. 2026
FIGURE 16 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 GLOBAL MARKET SHARE, BY TYPE, 2021 VS. 2026
FIGURE 17 IMPLANTABLE ELECTROCEUTICAL DEVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 GLOBAL MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 18 HOSPITALS, CLINICS, AND ASCS TO CONTINUE TO DOMINATE THE MARKET IN 2026
4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE ELECTROCEUTICALS MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders
5.2.1.2 Rising government support & funding for neurological disorders
FIGURE 21 FUNDING FOR RESEARCH BY THE NATIONAL INSTITUTES OF HEALTH (US)
5.2.1.3 Increasing investments and funding for research on CRM devices
5.2.2 RESTRAINTS
5.2.2.1 High cost of electroceutical devices
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 The dearth of trained professionals
5.2.4.2 Challenges associated with battery life and device replacement
5.3 IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET
5.4 RANGES/ SCENARIOS
5.4.1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
FIGURE 22 DEPENDING ON UNCERTAINTIES, THE FOLLOWING SCENARIOS HAVE BEEN ASSESSED FOR THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
5.5 PRICING ANALYSIS
TABLE 1 PRICE OF ELECTROCEUTICAL DEVICES (2021)
5.6 PATENT ANALYSIS
5.6.1 PATENT ANALYSIS OF CARDIAC PACEMAKERS
5.6.2 PATENT ANALYSIS OF COCHLEAR IMPLANTS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR PACEMAKERS
TABLE 2 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 3 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016–2020 (USD MILLION)
5.8 VALUE CHAIN ANALYSIS
FIGURE 23 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 24 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.10 ECOSYSTEM ANALYSIS OF THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET
FIGURE 25 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: ECOSYSTEM ANALYSIS
5.10.1 ROLE IN ECOSYSTEM
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 DEGREE OF COMPETITION
5.12 REGULATORY LANDSCAPE
5.12.1 NORTH AMERICA
5.12.1.1 US
5.12.1.2 Canada
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
5.12.3.2 India
5.12.4 LATIN AMERICA
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 MIDDLE EAST
5.13 TECHNOLOGY ANALYSIS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ELECTROCEUTICAL DEVICES MANUFACTURERS
5.14.2 REVENUE SHIFT FOR ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
6 ELECTROCEUTICALS MARKET, BY PRODUCT (Page No. - 79)
6.1 INTRODUCTION
TABLE 5 ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 6 GLOBAL MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS TO BOOST THE MARKET GROWTH OF THIS SEGMENT
TABLE 7 KEY PRODUCTS IN THE CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
TABLE 8 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 9 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3 SPINAL CORD STIMULATORS
TABLE 10 KEY PRODUCTS IN THE SPINAL CORD STIMULATORS MARKET
TABLE 11 SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 12 SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
6.3.1 CHRONIC PAIN
6.3.1.1 Spinal cord stimulation (SCS) is the standard procedure for patients with chronic pain in the back and limbs
TABLE 13 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2016–2019 (USD MILLION)
TABLE 14 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2020–2026 (USD MILLION)
6.3.2 FAILED BACK SURGERY SYNDROME
6.3.2.1 Introduction of alternative therapies to restrain the market growth
TABLE 15 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2016–2019 (USD MILLION)
TABLE 16 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2020–2026 (USD MILLION)
6.3.3 CEREBRAL ISCHEMIA
6.3.3.1 High incidence of ischemia to drive the market growth for spinal cord stimulators
TABLE 17 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA, BY REGION, 2016–2019 (USD MILLION)
TABLE 18 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA, BY REGION, 2020–2026 (USD MILLION)
6.4 COCHLEAR IMPLANTS
6.4.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET DEMAND FOR COCHLEAR IMPLANTS
TABLE 19 KEY DEVICES IN THE COCHLEAR IMPLANTS MARKET
TABLE 20 COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 21 COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.5 DEEP BRAIN STIMULATORS
TABLE 22 KEY DEVICES IN THE DEEP BRAIN STIMULATORS MARKET
TABLE 23 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 24 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
6.5.1 PARKINSON’S DISEASE
6.5.1.1 The rising incidence of Parkinson’s disease and growing R&D activities in this field is likely to drive market growth
TABLE 25 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2016–2019 (USD MILLION)
TABLE 26 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2020–2026 (USD MILLION)
6.5.2 TREMORS
6.5.2.1 The high efficiency of DBS in treating tremors has boosted the market demand for deep brain stimulators
TABLE 27 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2016–2019 (USD MILLION)
TABLE 28 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2020–2026 (USD MILLION)
6.5.3 DEPRESSION
6.5.3.1 The use of DBS in the treatment of depression is restrained by a lack of evidence for its efficacy
TABLE 29 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2016–2019 (USD MILLION)
TABLE 30 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2020–2026 (USD MILLION)
6.5.4 OTHER DBS APPLICATIONS
TABLE 31 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 32 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
6.6 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS
TABLE 33 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 34 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
6.6.1 URINARY INCONTINENCE
6.6.1.1 High incidence of urinary incontinence to offer growth opportunities for sacral nerve stimulators
TABLE 35 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE, BY REGION, 2016–2019 (USD MILLION)
TABLE 36 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE, BY REGION, 2020–2026 (USD MILLION)
6.6.2 GASTROPARESIS
6.6.2.1 Gastric electrical stimulation treatment reduces the hospital stay duration for patients affected by gastroparesis
TABLE 37 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2016–2019 (USD MILLION)
TABLE 38 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2020–2026 (USD MILLION)
6.6.3 FECAL INCONTINENCE
6.6.3.1 High reductions in symptom recurrence have supported the use of sacral nerve stimulators in fecal incontinence treatment
TABLE 39 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2016–2019 (USD MILLION)
TABLE 40 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2020–2026 (USD MILLION)
6.7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
TABLE 41 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 42 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
6.7.1 TREATMENT-RESISTANT DEPRESSION
6.7.1.1 High prevalence of depression to support the market growth
TABLE 43 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2016–2019 (USD MILLION)
TABLE 44 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2020–2026 (USD MILLION)
6.7.2 OTHER TENS APPLICATIONS
TABLE 45 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER TENS APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 46 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER TENS APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
6.8 VAGUS NERVE STIMULATORS
TABLE 47 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 48 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
6.8.1 EPILEPSY
6.8.1.1 Advantages associated with VNS in the treatment of epilepsy are expected to drive the market growth
TABLE 49 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2016–2019 (USD MILLION)
TABLE 50 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2020–2026 (USD MILLION)
6.8.2 OTHER VNS APPLICATIONS
TABLE 51 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 52 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
6.9 OTHER ELECTRICAL STIMULATORS
TABLE 53 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 54 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION, 2020–2026 (USD MILLION)
7 ELECTROCEUTICALS MARKET, BY TYPE (Page No. - 113)
7.1 INTRODUCTION
TABLE 55 ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 56 GLOBAL MARKET, BY TYPE, 2020–2026 (USD MILLION)
7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES
7.2.1 LONG TERM COST SAVINGS ASSOCIATED WITH THE USE OF THESE DEVICES TO DRIVE THE MARKET GROWTH
TABLE 57 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 58 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)
7.3 NONINVASIVE ELECTROCEUTICAL DEVICES
7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COSTS TO DRIVE THE MARKET GROWTH FOR NONINVASIVE DEVICES
TABLE 59 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 60 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)
8 ELECTROCEUTICALS MARKET, BY END USER (Page No. - 120)
8.1 INTRODUCTION
TABLE 61 ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 62 GLOBAL MARKET, BY END USER, 2020–2026 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND ASCS
8.2.1 GROWING NUMBER OF SURGERIES PERFORMED IN HOSPITALS AND ASCS TO SUPPORT THE MARKET GROWTH
TABLE 63 GLOBAL MARKET FOR HOSPITALS, CLINICS, AND ASCS, BY REGION, 2016–2019 (USD MILLION)
TABLE 64 GLOBAL MARKET FOR HOSPITALS, CLINICS, AND ASCS, BY REGION, 2020–2026 (USD MILLION)
8.3 OTHER END USERS
TABLE 65 ELECTROCEUTICALS MARKET FOR OTHER END USERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 66 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)
9 ELECTROCEUTICALS MARKET, BY REGION (Page No. - 126)
9.1 INTRODUCTION
TABLE 67 ELECTROCEUTICALS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 68 GLOBAL MARKET, BY REGION, 2020–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
TABLE 69 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 72 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American electroceuticals market in 2020
TABLE 73 US: KEY MACROINDICATORS
TABLE 74 US: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 75 US: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 76 US: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 77 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 78 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 79 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 80 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 81 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 82 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 83 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 84 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 85 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 86 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 87 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 88 US: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 89 US: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable environment for R&D in cardiology and neurosciences to drive the market growth
TABLE 90 NEUROLOGICAL CONDITIONS IN CANADA
TABLE 91 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 92 CANADA: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 93 CANADA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 94 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 95 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 96 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 97 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 98 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 99 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 100 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 101 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 102 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 103 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 104 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 105 CANADA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 106 CANADA: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3 EUROPE
TABLE 107 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 108 EUROPE: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 109 EUROPE: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 110 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominated the European electroceuticals market in 2020
TABLE 111 GERMANY: KEY MACROINDICATORS
TABLE 112 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 113 GERMANY: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 114 GERMANY: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 115 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 116 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 117 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 118 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 119 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 120 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 121 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 122 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 123 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 124 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 125 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 126 GERMANY: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 127 GERMANY: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing investments and funding by the government to drive the market growth in the UK
TABLE 128 UK: KEY MACROINDICATORS
TABLE 129 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 130 UK: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 131 UK: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 132 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 133 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 134 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 135 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 136 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 137 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 138 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 139 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 140 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 141 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 142 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 143 UK: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 144 UK: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.3 REST OF EUROPE
TABLE 145 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 146 ROE: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 147 ROE: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 148 ROE: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 149 ROE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 150 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 151 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 152 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 153 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 154 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 155 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 156 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 157 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 158 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 159 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 160 ROE: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 161 ROE: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
TABLE 162 APAC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 163 APAC: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 164 APAC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 165 APAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC market for electroceutical devices in 2020
TABLE 166 CHINA: KEY MACROINDICATORS
TABLE 167 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 168 CHINA: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 169 CHINA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 170 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 171 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 172 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 173 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 174 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 175 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 176 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 177 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 178 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 179 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 180 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 181 CHINA: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 182 CHINA: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 The elderly population in Japan drives the market growth for electroceutical devices
TABLE 183 JAPAN: KEY MACROINDICATORS
TABLE 184 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 185 JAPAN: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 186 JAPAN: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 187 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 188 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 189 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 190 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 191 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 192 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 193 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 194 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 195 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 196 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 197 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 198 JAPAN: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 199 JAPAN: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 200 ROAPAC: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 201 ROAPAC: MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 202 ROAPAC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 203 ROAPAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 204 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 205 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 206 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 207 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 208 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 209 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 210 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 211 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 212 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 213 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 214 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 215 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH
TABLE 216 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 217 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE IN THE REGION TO SUPPORT THE MARKET GROWTH
TABLE 218 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 195)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
TABLE 220 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ELECTROCEUTICAL DEVICES MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 28 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 29 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SHARE, BY KEY PLAYER (2020)
TABLE 221 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 30 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 31 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 32 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
TABLE 222 COMPANY PRODUCT TYPE FOOTPRINT
TABLE 223 COMPANY GEOGRAPHICAL FOOTPRINT
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 224 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 225 KEY DEALS
11 COMPANY PROFILES (Page No. - 207)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats)*
11.1.1 MEDTRONIC PLC
TABLE 226 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.2 ABBOTT LABORATORIES, INC.
TABLE 227 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 34 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 228 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
11.1.4 COCHLEAR LTD.
TABLE 229 COCHLEAR LTD.: BUSINESS OVERVIEW
FIGURE 36 COCHLEAR LTD.: COMPANY SNAPSHOT (2020)
11.1.5 LIVANOVA PLC
TABLE 230 LIVANOVA PLC: BUSINESS OVERVIEW
FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020)
11.1.6 MICROPORT SCIENTIFIC CORPORATION
TABLE 231 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 38 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.1.7 SONOVA GROUP
TABLE 232 SONOVA GROUP: BUSINESS OVERVIEW
FIGURE 39 SONOVA GROUP: COMPANY SNAPSHOT (2019)
11.1.8 NEVRO CORP.
TABLE 233 NEVRO CORP.: BUSINESS OVERVIEW
FIGURE 40 NEVRO CORP.: COMPANY SNAPSHOT (2020)
11.1.9 AXONICS MODULATION TECHNOLOGIES, INC.
TABLE 234 AXONICS MODULATION TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 41 AXONICS MODULATION TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
11.1.10 SECOND SIGHT MEDICAL PRODUCTS, INC.
TABLE 235 SECOND SIGHT MEDICAL PRODUCTS, INC.: BUSINESS OVERVIEW
FIGURE 42 SECOND SIGHT MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT (2019)
11.2 OTHER PLAYERS
11.2.1 NEURONETICS, INC.
TABLE 236 NEURONETICS, INC.: BUSINESS OVERVIEW
FIGURE 43 NEURONETICS, INC.: COMPANY SNAPSHOT (2020)
11.2.2 NEUROPACE, INC.
TABLE 237 NEUROPACE, INC.: BUSINESS OVERVIEW
11.2.3 BIOTRONIK
TABLE 238 BIOTRONIK: BUSINESS OVERVIEW
11.2.4 MEDICO S.P.A.
TABLE 239 MEDICO S.P.A.: BUSINESS OVERVIEW
11.2.5 NUROTRON BIOTECHNOLOGY CO. LTD.
TABLE 240 NUROTRON BIOTECHNOLOGY CO. LTD.: BUSINESS OVERVIEW
11.2.6 MED-EL
TABLE 241 MED-EL: BUSINESS OVERVIEW
11.2.7 ALEVA NEUROTHERAPEUTICS SA
TABLE 242 ALEVA NEUROTHERAPEUTICS SA: BUSINESS OVERVIEW
11.2.8 NEUROSIGMA, INC.
TABLE 243 NEUROSIGMA, INC.: BUSINESS OVERVIEW
11.2.9 BIOWAVE CORPORATION
TABLE 244 BIOWAVE CORPORATION: BUSINESS OVERVIEW
11.2.10 SOTERIX MEDICAL INC.
TABLE 245 SOTERIX MEDICAL INC.: BUSINESS OVERVIEW
11.2.11 BIOINDUCTION LTD
TABLE 246 BIOINDUCTION LTD: BUSINESS OVERVIEW
11.2.12 GIMER MEDICAL
TABLE 247 GIMER MEDICAL: BUSINESS OVERVIEW
11.2.13 CEFALY
TABLE 248 CEFALY: BUSINESS OVERVIEW
11.2.14 BIOCONTROL MEDICAL
TABLE 249 BIOCONTROL MEDICAL: BUSINESS OVERVIEW
11.2.15 TVNS TECHNOLOGIES GMBH
TABLE 250 TVNS TECHNOLOGIES GMBH: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 256)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the electroceuticals market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the electroceuticals market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the electroceuticals market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global electroceuticals market by product, type, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall electroceuticals market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches, regulatory approvals, collaborations, agreements, and acquisitions in the electroceuticals market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
- Electroceuticals market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
- Additional five company profiles of players operating in the electroceuticals market
Generating Response ...
Growth opportunities and latent adjacency in Electroceuticals Market
Research and sales information of Electroceuticals Market / Bioelectric Medicine Market
Insights on current market scenario of Bioelectric Medicine Market